Sanuwave Health Inc (SNWV) Stock Price, Quote & News

Company Profile

SANUWAVE Health, Inc. operates as a medical device company in the United States and internationally. It focuses on the commercialization of regenerative medicines through noninvasive ultrasound or shockwaves to produce a biological response promoting the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company markets UltraMist system, a medical device that uses non-thermal ultrasound to treat tissues using a fluid mist to transmit energy in a non-contact and pain...

Industry: Medical Devices

Sector: Healthcare

Phone: 952 656 1029

Website: sanuwave.com

Address:

9600 W. 76th Street, Suite 118, Eden Prairie, United States

topstockalerts Jul. 9 at 11:39 PM

$SNWV feels like it’s setting up for another push

0 · Reply

Larry_wildman Jul. 9 at 6:47 PM

$SNWV Great call TenFolds

0 · Reply

Benderama8 Jun. 28 at 1:50 PM

$SNWV Still seems expensive, 75m market cap and not profitable.

1 · Reply

TenFolds Jun. 27 at 5:42 AM

$SNWV happy to start a 1% position at $8.26. let's go let's go

0 · Reply

Mikeqb20 Jun. 25 at 7:36 PM

$SNWV

0 · Reply

peepthestamp Jun. 22 at 4:41 PM

$SNWV -Buy Lows

1 · Reply

thecontracap Jun. 17 at 1:48 AM

$SNWV ceo told us last qtr the bottom was in, then rugged us. This thing is going to take time to work, if it ever does.

1 · Reply

johnnylawrencecobra Jun. 16 at 10:36 PM

$SNWV disaster

0 · Reply

GlobalInsights Jun. 16 at 3:32 PM

$SNWV Wow, glad I don’t own any of this. I’ve been tracking it and was thinking about buying. Dodged a bullet. Shareholders puking in the streets this morning.

0 · Reply

yft212 Jun. 16 at 3:14 PM

$SNWV We remain optimistic about our pipeline and about our forward potential, but from a capital sales standpoint, this is going to be some near-term wood to chop.” Let's start with cutting the dead wood and fire the CEO.

0 · Reply

SANUWAVE Health Transcript: Planet MicroCap Las Vegas 2026

Jun 16, 2026, 8:00 AM EDT - 23 days ago

Sanuwave Health Updates Second Quarter 2026 Guidance

Jun 16, 2026, 7:00 AM EDT - 23 days ago

SANUWAVE Health Slides: Investor presentation

Jun 11, 2026, 11:00 AM EDT - 4 weeks ago

SANUWAVE Health Transcript: AGM 2026

May 13, 2026, 8:30 AM EDT - 2 months ago

SANUWAVE Health Earnings Call Transcript: Q1 2026

May 13, 2026, 8:30 AM EDT - 2 months ago

SANUWAVE Health Quarterly report: Q1 2026

May 13, 2026, 8:30 AM EDT - 2 months ago

SANUWAVE Health Earnings release: Q1 2026

May 13, 2026, 8:30 AM EDT - 2 months ago

SANUWAVE Health Slides: Q1 2026

2026-05-12T22:32:44.000Z - 2 months ago

Sanuwave Health reports Q1 EPS (17c) vs (72c) last year

2026-05-12T22:30:53.000Z - 2 months ago

Sanuwave Health sees Q2 revenue $11.1M-$11.6M, one estimate $11.5M

2026-05-12T22:30:19.000Z - 2 months ago

Sanuwave Health backs FY26 revenue view $51M-$55M, one estimate $51.35M

May 12, 2026, 5:00 PM EDT - 2 months ago

Sanuwave Announces Revenues and Financial Results for Q1 FY2026

May 6, 2026, 5:00 PM EDT - 2 months ago

Sanuwave Will Host a Conference Call on May 13, 2026 at 8:30 AM (ET) to Present Q1 2026 Financial Results

Apr 29, 2026, 8:00 AM EDT - 2 months ago

SANUWAVE Health Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 2 months ago

SANUWAVE Health Proxy statement: Proxy filing

2026-04-16T21:05:43.000Z - 3 months ago

Sanuwave Health narrows Q1 revenue view to $9.6M-$9.7M from $9.6M-$10.3M

2026-03-27T17:30:15.000Z - 3 months ago

Sanuwave Health price target lowered to $47 from $53 at Roth Capital

Mar 27, 2026, 8:30 AM EDT - 3 months ago

SANUWAVE Health Earnings Call Transcript: Q4 2025

Mar 27, 2026, 8:30 AM EDT - 3 months ago

SANUWAVE Health Earnings release: Q4 2025

Mar 27, 2026, 8:30 AM EDT - 3 months ago

SANUWAVE Health Annual report: Q4 2025

Mar 27, 2026, 8:30 AM EDT - 3 months ago

SANUWAVE Health Slides: Q4 2025

2026-03-26T21:06:12.000Z - 3 months ago

Sanuwave Health reports Q4 adjusted EBITDA $4.77M vs $3.66M last year

2026-03-26T21:05:53.000Z - 3 months ago

Sanuwave Health sees Q1 revenue $9.6M-$10.3M

2026-03-26T21:05:43.000Z - 3 months ago

Sanuwave Health sees FY26 revenue $51M-$55M

Mar 26, 2026, 5:00 PM EDT - 3 months ago

Sanuwave Announces Record Revenues and Financial Results for Q4 and Full Year 2025

Mar 20, 2026, 1:30 PM EDT - 3 months ago

Sanuwave Will Host a Conference Call on March 27, 2026 at 8:30 AM (ET) to Present Q4 and Full Year 2025 Financial Results

2026-01-12T13:06:56.000Z - 6 months ago

Sanuwave Health sees Q4 revenue $13.3M-$13.4M, up 29%-30% y/y

Jan 9, 2026, 5:00 AM EST - 6 months ago

Sanuwave Health Announces Preliminary Q4 2025 Revenue of $13.3–$13.4 Million, Up 29–30% Year-over-Year; Achieves Record Quarterly and Full-Year Revenue

2025-12-08T15:35:06.000Z - 7 months ago

Roth Capital views Sanuwave Health’s UltraMIST news as ‘highly favorable’

Dec 8, 2025, 6:00 AM EST - 7 months ago

Sanuwave Announces the Addition of UltraMIST to Healogics Group Purchasing Organization (GPO), iSupply

Nov 7, 2025, 8:30 AM EST - 8 months ago

SANUWAVE Health Earnings Call Transcript: Q3 2025

Nov 7, 2025, 8:30 AM EST - 8 months ago

SANUWAVE Health Earnings release: Q3 2025

Nov 7, 2025, 8:30 AM EST - 8 months ago

SANUWAVE Health Quarterly report: Q3 2025

Nov 7, 2025, 8:30 AM EST - 8 months ago

SANUWAVE Health Slides: Q3 2025

2025-11-07T11:26:30.000Z - 8 months ago

Sanuwave Health reports Q3 EPS 46c vs. ($6.49) last year

2025-11-07T11:26:05.000Z - 8 months ago

Sanuwave Health sees Q4 revenue $13M-$14M

Nov 7, 2025, 6:00 AM EST - 8 months ago

Sanuwave Announces Q3 FY2025 Financial Results

Nov 3, 2025, 4:35 PM EST - 8 months ago

Sanuwave Will Host a Conference Call on November 7, 2025 at 8:30 AM (ET) to Present Q3 2025 Financial Results

2025-10-07T11:50:21.000Z - 9 months ago

Sanuwave Health price target lowered to $53 from $55 at Roth Capital

2025-10-06T20:40:28.000Z - 9 months ago

Sanuwave Health cuts FY25 revenue view to $44M-$46M from $48M-$50M

2025-10-06T20:35:10.000Z - 9 months ago

Sanuwave Health cuts Q3 revenue view to $11.4M-$11.6M from $12M-$12.7M

Oct 6, 2025, 4:01 PM EDT - 9 months ago

Sanuwave Health Announces Preliminary Revenue Results for the Third Quarter 2025 (Ended September 30, 2025)

2025-09-26T11:05:15.000Z - 10 months ago

Sanuwave Health announces debt refinancing with new credit facility

Sep 26, 2025, 7:00 AM EDT - 10 months ago

Sanuwave Announces Strategic Debt Refinancing with New Credit Facility

Aug 19, 2025, 11:00 AM EDT - 11 months ago

SANUWAVE Health Transcript: AGM 2025

Aug 8, 2025, 8:30 AM EDT - 11 months ago

SANUWAVE Health Earnings Call Transcript: Q2 2025

Aug 8, 2025, 8:30 AM EDT - 11 months ago

SANUWAVE Health Earnings release: Q2 2025

Aug 8, 2025, 8:30 AM EDT - 11 months ago

SANUWAVE Health Quarterly report: Q2 2025

Aug 8, 2025, 8:30 AM EDT - 11 months ago

SANUWAVE Health Slides: Q2 2025

Aug 8, 2025, 6:00 AM EDT - 11 months ago

Sanuwave Announces Q2 FY2025 Financial Results

Aug 4, 2025, 5:00 PM EDT - 1 year ago

Sanuwave Will Host a Conference Call on August 8, 2025 at 8:30 AM (ET) to Present Q2 2025 Financial Results

Jul 22, 2025, 4:05 PM EDT - 1 year ago

Sanuwave Health to Present at Canaccord Genuity Growth Conference

Jul 10, 2025, 8:00 AM EDT - 1 year ago

SANUWAVE Health Proxy statement: Proxy Filing

Jul 10, 2025, 8:00 AM EDT - 1 year ago

SANUWAVE Health Proxy statement: Proxy Filing

Jun 3, 2025, 7:30 AM EDT - 1 year ago

Sanuwave Health Appoints Industry Veteran Dustin Libby as Executive Vice President of Commercial Operations

May 28, 2025, 4:10 PM EDT - 1 year ago

Sanuwave Health Selected for Inclusion in Russell 2000® Index

May 28, 2025, 4:05 PM EDT - 1 year ago

Sanuwave Health Appoints Greg Bazar to Board of Directors

May 9, 2025, 8:30 AM EDT - 1 year ago

SANUWAVE Health Earnings Call Transcript: Q1 2025

May 9, 2025, 8:30 AM EDT - 1 year ago

SANUWAVE Health Quarterly report: Q1 2025

May 9, 2025, 8:30 AM EDT - 1 year ago

SANUWAVE Health Earnings release: Q1 2025

May 9, 2025, 8:30 AM EDT - 1 year ago

SANUWAVE Health Slides: Q1 2025

May 9, 2025, 6:00 AM EDT - 1 year ago

Sanuwave Announces Q1 FY2025 Financial Results

May 5, 2025, 5:00 PM EDT - 1 year ago

Sanuwave Will Host a Conference Call on May 9, 2025 at 8:30 AM (ET) to Present Q1 2025 Financial Results

Apr 8, 2025, 8:30 AM EDT - 1 year ago

SANUWAVE Health Announces Preliminary Revenue Results for the First Quarter 2025 (Ended March 31, 2025)

Mar 21, 2025, 8:30 AM EDT - 1 year ago

SANUWAVE Health Earnings Call Transcript: Q4 2024

Mar 21, 2025, 8:30 AM EDT - 1 year ago

SANUWAVE Health Annual report: Q4 2024

Mar 21, 2025, 8:30 AM EDT - 1 year ago

SANUWAVE Health Earnings release: Q4 2024

Mar 21, 2025, 8:30 AM EDT - 1 year ago

SANUWAVE Health Slides: Q4 2024

Mar 21, 2025, 6:00 AM EDT - 1 year ago

SANUWAVE Announces Record Quarterly Revenues: Q4 FY2024 Financial Results

Mar 17, 2025, 8:00 AM EDT - 1 year ago

SANUWAVE Will Host a Conference Call on March 21, 2025 at 8:30 AM (ET) to Present Q4 and Full Year 2024 Financial Results

Mar 4, 2025, 4:06 PM EST - 1 year ago

Sanuwave Health to Uplist to the Nasdaq Global Market

Feb 19, 2025, 9:04 AM EST - 1 year ago

SANUWAVE Health to Participate in 37th Annual Roth Conference

Dec 3, 2024, 7:00 AM EST - 1 year ago

SANUWAVE Health Registration statement: Registration Filing

Nov 8, 2024, 8:30 AM EST - 1 year ago

SANUWAVE Health Earnings Call Transcript: Q3 2024

Nov 8, 2024, 8:30 AM EST - 1 year ago

SANUWAVE Health Quarterly report: Q3 2024

Nov 8, 2024, 8:30 AM EST - 1 year ago

SANUWAVE Health Earnings release: Q3 2024

Nov 8, 2024, 8:30 AM EST - 1 year ago

SANUWAVE Health Slides: Q3 2024

Nov 8, 2024, 6:00 AM EST - 1 year ago

SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results

Nov 4, 2024, 7:30 AM EST - 1 year ago

SANUWAVE Will Host a Conference Call on November 8, 2024 at 8:30 AM (ET) to Present Q3 Financial Results

Oct 16, 2024, 7:30 AM EDT - 1 year ago

SANUWAVE Health Announces 1-For-375 Reverse Stock Split

Aug 13, 2024, 8:30 AM EDT - 2 years ago

SANUWAVE Health Earnings Call Transcript: Q2 2024

Aug 13, 2024, 8:30 AM EDT - 2 years ago

SANUWAVE Health Quarterly report: Q2 2024

Aug 13, 2024, 8:30 AM EDT - 2 years ago

SANUWAVE Health Earnings release: Q2 2024

Aug 13, 2024, 6:00 AM EDT - 2 years ago

SANUWAVE Announces Record Quarterly Revenues: Q2 FY2024 Financial Results

Aug 7, 2024, 6:51 PM EDT - 2 years ago

SANUWAVE Will Host a Conference Call on August 13, 2024 at 8:30 AM (ET) to Present Q2 Financial Results

Jul 18, 2024, 8:00 AM EDT - 2 years ago

SANUWAVE Health Proxy statement: Proxy Filing

Jul 8, 2024, 8:00 AM EDT - 2 years ago

SANUWAVE Health Proxy statement: Proxy Filing

Jun 4, 2024, 8:30 AM EDT - 2 years ago

SANUWAVE Health Transcript: M&A Announcement

Jun 4, 2024, 8:30 AM EDT - 2 years ago

SANUWAVE Health Press release: M&A Announcement

May 10, 2024, 8:30 AM EDT - 2 years ago

SANUWAVE Health Earnings Call Transcript: Q1 2024

May 10, 2024, 8:30 AM EDT - 2 years ago

SANUWAVE Health Quarterly report: Q1 2024

May 10, 2024, 8:30 AM EDT - 2 years ago

SANUWAVE Health Earnings release: Q1 2024

May 10, 2024, 8:30 AM EDT - 2 years ago

SANUWAVE Health Slides: Q1 2024

Apr 10, 2024, 8:30 AM EDT - 2 years ago

SANUWAVE Health Announces Preliminary Revenue Results for the First Quarter 2024 (Ended March 31, 2024)

Apr 1, 2024, 4:00 PM EDT - 2 years ago

SANUWAVE Health Appoints Industry Veteran Peter Sorensen as Chief Financial Officer

Mar 22, 2024, 8:30 AM EDT - 2 years ago

SANUWAVE Health Earnings Call Transcript: Q4 2023

Mar 22, 2024, 8:30 AM EDT - 2 years ago

SANUWAVE Health Annual report: Q4 2023

Mar 22, 2024, 8:30 AM EDT - 2 years ago

SANUWAVE Health Earnings release: Q4 2023

Mar 22, 2024, 8:30 AM EDT - 2 years ago

SANUWAVE Health Slides: Q4 2023

Mar 22, 2024, 6:00 AM EDT - 2 years ago

SANUWAVE Announces Record Q4 and FY2023 Revenue

Mar 20, 2024, 7:00 AM EDT - 2 years ago

SANUWAVE Will Host a Conference Call on March 22, 2024 at 8:30 AM (ET) to Present the Q4 and FY2023 Financial Results

Feb 22, 2024, 5:00 PM EST - 2 years ago

SANUWAVE Health Reports Stockholder Approval of SEPA Merger at Special Meeting of Stockholders

Feb 21, 2024, 11:00 AM EST - 2 years ago

SANUWAVE Health Transcript: AGM 2024

Jan 22, 2024, 7:59 AM EST - 2 years ago

SANUWAVE Announces Special Meeting of Stockholders to Vote on Business Combination with SEP Acquisition Corp. (Nasdaq: SEPA)

Jan 22, 2024, 7:00 AM EST - 2 years ago

SANUWAVE Health Proxy statement: Proxy Filing

Jan 12, 2024, 7:00 AM EST - 2 years ago

SANUWAVE Health Proxy statement: Proxy Filing

Jan 10, 2024, 7:00 AM EST - 2 years ago

SANUWAVE Health Announces Preliminary Revenue Results for the Fourth Quarter and Fiscal Year 2023, Ended December 31, 2023

Nov 10, 2023, 8:00 AM EST - 2 years ago

SANUWAVE Health Earnings Call Transcript: Q3 2023

Nov 10, 2023, 8:00 AM EST - 2 years ago

SANUWAVE Health Quarterly report: Q3 2023

Nov 10, 2023, 8:00 AM EST - 2 years ago

SANUWAVE Health Earnings release: Q3 2023

Nov 10, 2023, 5:00 AM EST - 2 years ago

SANUWAVE Announces Q3 2023 Financial Results

Nov 8, 2023, 4:30 PM EST - 2 years ago

SANUWAVE Will Host a Conference Call on November 10, 2023 at 8:00 AM (ET) to Present the Q3 2023 Financial Results

Oct 10, 2023, 7:30 AM EDT - 2 years ago

SANUWAVE Health Announces Preliminary Revenue Results for the Third Quarter Ended September 30, 2023

Sep 29, 2023, 8:00 AM EDT - 3 years ago

SANUWAVE Health Registration statement: Registration Filing

Aug 23, 2023, 4:30 PM EDT - 3 years ago

SANUWAVE Health, Inc., a Leading Provider of FDA Approved Next-Generation Wound Care Products, Enters into a Merger Agreement with Sweat Equity Partners and Mercury Life Sciences-affiliated SEP Acquisition Corp., a Nasdaq-Listed Company

Aug 11, 2023, 8:30 AM EDT - 3 years ago

SANUWAVE Health Earnings Call Transcript: Q2 2023

Aug 11, 2023, 8:30 AM EDT - 3 years ago

SANUWAVE Health Quarterly report: Q2 2023

Aug 11, 2023, 8:30 AM EDT - 3 years ago

SANUWAVE Health Earnings release: Q2 2023

Aug 11, 2023, 8:30 AM EDT - 3 years ago

SANUWAVE Health Slides: Q2 2023

Aug 11, 2023, 6:00 AM EDT - 3 years ago

SANUWAVE Announces Q2 2023 Financial Results

Aug 9, 2023, 5:22 PM EDT - 3 years ago

SANUWAVE Will Host a Live Conference Call on August 11, 2023 at 8:30 AM (EDT) to Present Its Q2 2023 Financial Results

Aug 1, 2023, 7:30 AM EDT - 3 years ago

SANUWAVE Signs Distribution Agreement With Pacific Medical, Inc.

Jul 31, 2023, 7:30 AM EDT - 3 years ago

SANUWAVE Health Appoints Industry Veteran Andrew Walko as President

Jul 17, 2023, 7:30 AM EDT - 3 years ago

SANUWAVE Health Announces Preliminary Revenue Results for the Second Quarter Ended June 30, 2023

Jun 30, 2023, 8:00 AM EDT - 3 years ago

SANUWAVE Health Registration statement: Registration Filing

May 24, 2023, 9:00 AM EDT - 3 years ago

SANUWAVE Health, Inc. Appoints Morgan Frank as Chief Executive Officer

May 12, 2023, 9:00 AM EDT - 3 years ago

SANUWAVE Health Earnings Call Transcript: Q1 2023

May 12, 2023, 9:00 AM EDT - 3 years ago

SANUWAVE Health Quarterly report: Q1 2023

May 12, 2023, 9:00 AM EDT - 3 years ago

SANUWAVE Health Earnings release: Q1 2023

May 12, 2023, 9:00 AM EDT - 3 years ago

SANUWAVE Health Slides: Q1 2023

May 12, 2023, 7:30 AM EDT - 3 years ago

SANUWAVE Announces Q1 2023 Financial Results

May 11, 2023, 7:30 AM EDT - 3 years ago

SANUWAVE Will Host a Live Conference Call and Webcast May 12, 2023 at 9:00 AM to Provide a Financial and Business Update

Apr 27, 2023, 8:30 AM EDT - 3 years ago

SANUWAVE Health to Attend the 2023 Symposium on Advanced Wound Care (SAWC) Spring | Wound Healing Society (WHS) Conference

Apr 26, 2023, 8:30 AM EDT - 3 years ago

SANUWAVE Attends 3rd Annual Leaders in Wound Healing Conference

topstockalerts Jul. 9 at 11:39 PM

$SNWV feels like it’s setting up for another push

0 · Reply

Larry_wildman Jul. 9 at 6:47 PM

$SNWV Great call TenFolds

0 · Reply

Benderama8 Jun. 28 at 1:50 PM

$SNWV Still seems expensive, 75m market cap and not profitable.

1 · Reply

TenFolds Jun. 27 at 5:42 AM

$SNWV happy to start a 1% position at $8.26. let's go let's go

0 · Reply

Mikeqb20 Jun. 25 at 7:36 PM

$SNWV

0 · Reply

peepthestamp Jun. 22 at 4:41 PM

$SNWV -Buy Lows

1 · Reply

thecontracap Jun. 17 at 1:48 AM

$SNWV ceo told us last qtr the bottom was in, then rugged us. This thing is going to take time to work, if it ever does.

1 · Reply

johnnylawrencecobra Jun. 16 at 10:36 PM

$SNWV disaster

0 · Reply

GlobalInsights Jun. 16 at 3:32 PM

$SNWV Wow, glad I don’t own any of this. I’ve been tracking it and was thinking about buying. Dodged a bullet. Shareholders puking in the streets this morning.

0 · Reply

yft212 Jun. 16 at 3:14 PM

0 · Reply

RPFFPR Jun. 16 at 2:50 PM

$SNWV lowered guidance. https://sanuwave.com/investors/press-release-details?newsId=564dcce8-ce5b-4b35-8198-e5b37251e02e

0 · Reply

yft212 Jun. 16 at 2:13 PM

$SNWV current management has killed this company..

0 · Reply

GlobalInsights Jun. 16 at 12:50 PM

$SNWV What happened

1 · Reply

thecontracap Jun. 11 at 9:40 PM

$SNWV anyone here?

0 · Reply

thecontracap May. 28 at 6:48 PM

$SNWV growth re-accelerating thru the year after industry disruption in q1. This is trading at <10x EBITDA for a biz that will exit the year growing revenue 30%+. Cheapest profitable name in medtech

2 · Reply

IBCandBIOTECH May. 13 at 6:43 PM

$SNWV Let's go!!! Back to $30+

0 · Reply

MarketBeat May. 13 at 6:11 PM

https://marketbeat.com/a/8652822/ $SNWV Sanuwave Health Q1 Earnings Call Highlights

0 · Reply

StocktwitsEarnings May. 12 at 8:40 PM

$SNWV Q1 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.17 up 76.39% YoY • Reported revenue of $9.62M up 3.06% YoY • SANUWAVE forecasts Q2 2026 revenue of $11.1M to $11.6M, a 10-15% increase from Q2 2025, and reiterates full year 2026 revenue guidance of $51M.

0 · Reply

SuperGreenToday May. 6 at 12:41 PM

$SNWV

0 · Reply

johnnylawrencecobra May. 1 at 1:41 PM

$SNWV yep they are hammering it OpalEye are friends with Morgan too This is not good at all

0 · Reply

yft212 May. 1 at 1:26 PM

$SNWV https://www.investing.com/news/insider-trading-news/opaleye-management-sells-127m-in-sanuwave-health-stock-93CH-4651219

0 · Reply

yft212 Mar. 26 at 9:43 PM

$SNWV Well they're still up to their old trick of publishing "Record Results and Financial Results" but let's see how much they actually get to keep after their previously recorded (and botched) filings cost them additional taxes, interest and penalties. And let's see if they even bother to update investors March 27th. https://www.publicnow.com/view/DEE2A4E7783985D787D75AA2065C87B7C1980DDF

1 · Reply

Market Cap	269.20M
Revenue (ttm)	20.40M
Net Income (ttm)	-25.81M
EPS (ttm)	N/A
PE Ratio	3.53
Forward PE	N/A
Profit Margin	-126.52%
Debt to Equity Ratio	-0.41

Volume	33,500
Avg Vol	9,504
Day's Range	N/A - N/A
Shares Out	8.55M
Stochastic %K	51%
Beta	1.54
Analysts	Strong Buy
Price Target	$0.34